newsfilter
← Latest News
GlobeNewswire·

Imago BioSciences to Host Virtual Investor Event

SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- ​Imago BioSciences, Inc. ("Imago" or the "Company") (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (